טוען...
Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
Rapid vaccine development in response to an outbreak of a new emerging infectious disease (EID) is a goal targeted by public health agencies worldwide. This goal becomes more complicated when there are no standardized sets of viral and immunological assays, no accepted and well-characterized samples...
שמור ב:
| הוצא לאור ב: | Hum Vaccin Immunother |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816404/ https://ncbi.nlm.nih.gov/pubmed/31268394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1634992 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|